Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R DOWNING

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Leukemia|June 1, 1996
High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in TaiwanD C Liang, T B Chou, J S Chen, et al.
Leukemia|April 13, 2011
Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot studyA K Mitra, K Crews, S Pounds, et al.
Blood|June 1, 1996
Molecular analysis of t(11;19) breakpoints in childhood acute leukemiasJ E Rubnitz, F G Behm, A M Curcio-Brint, et al.
Blood|June 1, 1993
Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiencyF M Uckun, J R Downing, R Gunther, et al.
Blood|April 1, 1996
Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting ageF G Behm, S C Raimondi, J L Frestedt, et al.
Blood|December 31, 1997
12p abnormalities and the TEL gene (ETV6) in childhood acute lymphoblastic leukemiaS C Raimondi, S A Shurtleff, J R Downing, et al.
Blood|February 15, 1997
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group studyJ E Rubnitz, J J Shuster, V J Land, et al.
Blood|January 15, 1994
The der(11)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;11)(q21;q23)-containing acute lymphoblastic leukemiaJ R Downing, D R Head, S C Raimondi, et al.
Leukemia|May 26, 2007
MN1 overexpression is an important step in the development of inv(16) AMLC Carella, J Bonten, S Sirma, et al.
Leukemia|December 1, 1995
TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosisS A Shurtleff, A Buijs, F G Behm, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Leukemia|June 1, 1996
High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in TaiwanD C Liang, T B Chou, J S Chen, et al.
Leukemia|April 13, 2011
Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot studyA K Mitra, K Crews, S Pounds, et al.
Blood|June 1, 1996
Molecular analysis of t(11;19) breakpoints in childhood acute leukemiasJ E Rubnitz, F G Behm, A M Curcio-Brint, et al.
Blood|June 1, 1993
Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiencyF M Uckun, J R Downing, R Gunther, et al.
Blood|April 1, 1996
Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting ageF G Behm, S C Raimondi, J L Frestedt, et al.
Blood|December 31, 1997
12p abnormalities and the TEL gene (ETV6) in childhood acute lymphoblastic leukemiaS C Raimondi, S A Shurtleff, J R Downing, et al.
Blood|February 15, 1997
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group studyJ E Rubnitz, J J Shuster, V J Land, et al.
Blood|January 15, 1994
The der(11)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;11)(q21;q23)-containing acute lymphoblastic leukemiaJ R Downing, D R Head, S C Raimondi, et al.
Leukemia|May 26, 2007
MN1 overexpression is an important step in the development of inv(16) AMLC Carella, J Bonten, S Sirma, et al.
Leukemia|December 1, 1995
TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosisS A Shurtleff, A Buijs, F G Behm, et al.
Pageof 12